Skip to main content
Valplast Technologies Limited logo

Valplast Technologies Limited — Investor Relations & Filings

Ticker · 544565 ISIN · INE0QP701017 LEI · 8945007UOSMC6WR89902 BSE.NS Manufacturing
Open in API
Filings indexed 6 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country IN India
Listing BSE.NS 544565

About Valplast Technologies Limited

https://valplastech.com

Valplast Technologies Limited specializes in the development and distribution of advanced prosthetic solutions, primarily focusing on flexible partial denture systems. The company provides high-quality thermoplastic resins and specialized injection molding equipment used by dental laboratories to create biocompatible, metal-free dental prosthetics. Their flagship product, the Valplast Flexible Partial, is recognized for its durability, aesthetic integration with natural gingival tissue, and patient comfort. The company supports dental professionals through technical training, laboratory certification programs, and the supply of precision-engineered materials designed to replace traditional rigid metal-based frameworks. Their offerings emphasize minimally invasive and hypoallergenic alternatives for tooth replacement.

Recent filings

Filing Released Lang Actions
Revised Disclosure under Regulation 31(4) of SEBI(SAST) Regulation, 2011
Regulatory Filings Classification · 89% confidence The document is a statutory compliance disclosure under Regulation 31(4) of SEBI’s Substantial Acquisition and Takeover Regulations, filed with the stock exchange. It provides shareholding and encumbrance details of promoters rather than announcing financial results, management changes, or share issuances. This falls under general regulatory filings (miscellaneous compliance disclosures) rather than a specific report type like an annual or quarterly report.
2026-05-21 English
Recommended Payments of Final Dividend
Regulatory Filings Classification · 92% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations – an outcome of a Board meeting announcing audited standalone financial results, dividend recommendation, IPO fund utilization variation, and related corporate approvals. It is a compliance/regulatory announcement rather than a standalone annual report, earnings release, or financial report filing itself. Therefore it falls into the general “Regulatory Filings” category.
2026-05-20 English
Financial Results for the Year ended 31 March 2026
Interim / Quarterly Report Classification · 88% confidence The document is a formal Board Meeting outcome notice sent to BSE under SEBI LODR Regulation 30 and 33. It principally contains the Audited Financial Results (Standalone) for the half-year and full year ended March 31, 2026 (with full financial statements: P&L, Balance Sheet, Cash Flow) along with the Audit Report, dividend recommendation, IPO fund utilisation variation and meeting logistics. Although it is filed as an exchange disclosure, the presence of comprehensive interim/half-year and year-end financial statements (not just highlights) aligns it with an Interim/Quarterly Report filing. It is not a full annual report (10-K) or mere earnings release (highlights only), nor is it just a regulatory notice without substantive data. Thus, it best fits the Interim / Quarterly Report category (IR). FY 2026
2026-05-20 English
Outcome of the Board meeting held on 20th May 2026
Regulatory Filings Classification · 75% confidence The document is the formal Board Meeting outcome notice filed under SEBI LODR Reg 30/33. It announces audited standalone financial results, audit report and dividend recommendation, variation in IPO fund utilization and board approvals for general/ postal ballot and e-voting arrangements. It is a multi-item regulatory disclosure, not the full annual report, not a pure earnings highlights release, and not a quarterly/interim standalone report. It is a general regulatory filing under listing obligations. Therefore this is best classified as Regulatory Filings (RNS).
2026-05-20 English
Monitoring Agency report for the Quarter and Financial Year ended on 31st March,2026
Regulatory Filings Classification · 92% confidence The document is a letter submitted to the stock exchange under SEBI Listing Regulations enclosing the Monitoring Agency Report for the quarter and financial year ended March 31, 2026. This is a compliance filing under listing obligations rather than an Annual or Quarterly financial report, audit opinion, or investor presentation. It constitutes a regulatory submission of information (“Monitoring Agency report”) and thus falls into the general Regulatory Filings category (RNS).
2026-05-15 English
Valplast Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve 1. To consider and approve ....
Regulatory Filings Classification · 88% confidence The document is a short notice to the stock exchange under SEBI Listing Regulations (Regulation 29) informing of an upcoming Board of Directors meeting. It does not contain financial statements itself nor change in board composition, nor is it an earnings release or dividend notice by itself. It is a regulatory announcement/filling to comply with listing obligations. Therefore, it best fits the “Regulatory Filings” fallback category (RNS).
2026-05-15 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.